In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 23rd, 2009 | 26 | Yes |
Popular Name: 1-[(2,4-dichlorophenyl)methyl]-3-[5-[2-(methylamino)pyrimidin-4-yl]-2-thienyl]urea 1-[(2,4-dichlorophenyl)methyl]-3…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.38 | 8.25 | -12.2 | 3 | 6 | 0 | 79 | 408.314 | 5 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT3-2-E | Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2100 | 0.31 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 2100 | 0.31 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
Downregulation of ERBB2:ERBB3 signaling | |
G beta:gamma signalling through PI3Kgamma | |
GPVI-mediated activation cascade | |
Negative regulation of the PI3K/AKT network | |
PIP3 activates AKT signaling | |
VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.